These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 28802281)

  • 21. Resistance-mediating polymorphisms in Plasmodium falciparum infections in Kinshasa, Democratic Republic of the Congo.
    Mobula L; Lilley B; Tshefu AK; Rosenthal PJ
    Am J Trop Med Hyg; 2009 Apr; 80(4):555-8. PubMed ID: 19346374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of Plasmodium falciparum Molecular Markers of Antimalarial Drug Resistance in a Residual Malaria Focus Area in Sabah, Malaysia.
    Norahmad NA; Mohd Abd Razak MR; Abdullah NR; Sastu UR; Imwong M; Muniandy PK; Saat MN; Muhammad A; Jelip J; Tikuson M; Yusof N; Rundi C; Mudin RN; Syed Mohamed AF
    PLoS One; 2016; 11(10):e0165515. PubMed ID: 27788228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing prevalence of a novel triple-mutant dihydropteroate synthase genotype in Plasmodium falciparum in western Kenya.
    Lucchi NW; Okoth SA; Komino F; Onyona P; Goldman IF; Ljolje D; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3995-4002. PubMed ID: 25896703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Plasmodium Falciparum Resistance Genes to Common Antimalarial Drugs in Semi-urban Areas of Burkina Faso.
    Zida A; Tchekounou C; Soulama I; Zongo C; Sombié S; Nikiema S; Yanogo NJ; Sawadogo S; Kaboré FCA; Zoure OAZD; Sawadogo H; Sawadogo PM; Tibiri YNG; Guiguemde KT; Ily RP; Ouedraogo-Traoré R; Ouedraogo Y; Savadogo A
    Acta Parasitol; 2024 Mar; 69(1):910-921. PubMed ID: 38478177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High prevalence of sulfadoxine/pyrimethamine-resistant alleles of Plasmodium falciparum isolates in pregnant women at the time of introduction of intermittent preventive treatment with sulfadoxine/pyrimethamine in Gabon.
    Bouyou-Akotet MK; Mawili-Mboumba DP; Tchantchou Tde D; Kombila M
    J Antimicrob Chemother; 2010 Mar; 65(3):438-41. PubMed ID: 20053688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Field-based evidence for linkage of mutations associated with chloroquine (pfcrt/pfmdr1) and sulfadoxine-pyrimethamine (pfdhfr/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparum.
    Osman ME; Mockenhaupt FP; Bienzle U; Elbashir MI; Giha HA
    Infect Genet Evol; 2007 Jan; 7(1):52-9. PubMed ID: 16690361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular determination of antifolate resistance associated point mutations in Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthetase (dhps) genes among the field samples in Arunachal Pradesh.
    Sharma J; Khan SA; Dutta P; Mahanta J
    J Vector Borne Dis; 2015 Jun; 52(2):116-21. PubMed ID: 26119542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
    Tahar R; Basco LK
    Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Origins of the recent emergence of Plasmodium falciparum pyrimethamine resistance alleles in Madagascar.
    Andriantsoanirina V; Bouchier C; Tichit M; Jahevitra M; Rabearimanana S; Randrianjafy R; Ratsimbasoa A; Mercereau-Puijalon O; Durand R; Ménard D
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2323-9. PubMed ID: 20308388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Declining trend of Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles after the withdrawal of Sulfadoxine-Pyrimethamine in North Western Ethiopia.
    Tessema SK; Kassa M; Kebede A; Mohammed H; Leta GT; Woyessa A; Guma GT; Petros B
    PLoS One; 2015; 10(10):e0126943. PubMed ID: 26431464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of sulphadoxine/pyrimethamine resistance-conferring mutations of Plasmodium falciparum from Mozambique reveals the absence of the dihydrofolate reductase 164L mutant.
    Fernandes N; Figueiredo P; do Rosário VE; Cravo P
    Malar J; 2007 Mar; 6():35. PubMed ID: 17378942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular epidemiology of drug-resistant Plasmodium falciparum in Benguela province, Angola.
    Foumane Ngane V; Allico Djaman J; Culeux C; Piette N; Carnevale P; Besnard P; Fortes F; Basco LK; Tahar R
    Malar J; 2015 Mar; 14():113. PubMed ID: 25889865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High prevalence of dhfr and dhps molecular markers in Plasmodium falciparum in pregnant women of Nchelenge district, Northern Zambia.
    Siame MN; Mharakurwa S; Chipeta J; Thuma P; Michelo C
    Malar J; 2015 May; 14():190. PubMed ID: 25943379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Origins and spread of pfdhfr mutant alleles in Plasmodium falciparum.
    Mita T
    Acta Trop; 2010 Jun; 114(3):166-70. PubMed ID: 19607799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.
    Mugittu K; Ndejembi M; Malisa A; Lemnge M; Premji Z; Mwita A; Nkya W; Kataraihya J; Abdulla S; Beck HP; Mshinda H
    Am J Trop Med Hyg; 2004 Dec; 71(6):696-702. PubMed ID: 15642957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of pfdhfr-pfdhps triple mutations associated with anti-malarial drugs resistance in Plasmodium falciparum isolates seven years after the adoption of sulfadoxine-pyrimethamine in combination with artesunate as first-line treatment in Iran.
    Rouhani M; Zakeri S; Pirahmadi S; Raeisi A; Djadid ND
    Infect Genet Evol; 2015 Apr; 31():183-9. PubMed ID: 25653131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of Mutations in the
    Issa I; Lamine MM; Hubert V; Ilagouma A; Adehossi E; Mahamadou A; Lobo NF; Sarr D; Shollenberger LM; Sandrine H; Jambou R; Laminou IM
    Trop Med Infect Dis; 2022 Jul; 7(8):. PubMed ID: 36006247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics.
    A-Elbasit IE; Alifrangis M; Khalil IF; Bygbjerg IC; Masuadi EM; Elbashir MI; Giha HA
    Malar J; 2007 Aug; 6():108. PubMed ID: 17686173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Markers of sulfadoxine-pyrimethamine-resistant Plasmodium falciparum in placenta and circulation of pregnant women.
    Mockenhaupt FP; Bedu-Addo G; Junge C; Hommerich L; Eggelte TA; Bienzle U
    Antimicrob Agents Chemother; 2007 Jan; 51(1):332-4. PubMed ID: 17088491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High chloroquine treatment failure rates and predominance of mutant genotypes associated with chloroquine and antifolate resistance among falciparum malaria patients from the island of Car Nicobar, India.
    Das MK; Lumb V; Mittra P; Singh SS; Dash AP; Sharma YD
    J Antimicrob Chemother; 2010 Jun; 65(6):1258-61. PubMed ID: 20363804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.